Translate to...

Antibody drug lowers risk of death in elderly covid-19 patients - Cuban study

Researchers, including from Cuba's Center of Molecular Immunology, which developed itolizumab, said timely use of the drug in combination with standard therapy helped reduce inflammation and prevented covid-19 from worsening.